Showing results (421-430 of 476) with videos related to
Sort By:
Pageof 48
Journal of the American Heart Association|December 11, 2025
Polygenic Risk Scores for Preeclampsia Prediction Beyond Gold-Standard Clinical Models in Multiethnic PopulationsMaddalena Ardissino, Kypros Nicolaides, Frances Conti-Ramsden, et al.Journal of Hepatology|December 15, 2010
Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infectionMichael P Manns, Marc Bourlière, Yves Benhamou, et al.Statistics in Biopharmaceutical Research|June 30, 2021
Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 PandemicR Daniel Meyer, Bohdana Ratitch, Marcel Wolbers, et al.The Journal of Infectious Diseases|January 22, 2014
Dolutegravir in antiretroviral-experienced patients with raltegravir- and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 studyAntonella Castagna, Franco Maggiolo, Giovanni Penco, et al.Transfusion|September 25, 2012
Motivation and social capital among prospective blood donors in three large blood centers in BrazilThelma T Gonçalez, Claudia Di Lorenzo Oliveira, Anna Barbara F Carneiro-Proietti, et al.American Journal of Obstetrics and Gynecology|August 9, 2017
Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical historyLiona C Poon, David Wright, Daniel L Rolnik, et al.Journal of Neuro-Oncology|August 9, 2019
Phase I/II study of bevacizumab with BKM120, an oral PI3K inhibitor, in patients with refractory solid tumors (phase I) and relapsed/refractory glioblastoma (phase II)John D Hainsworth, Kevin P Becker, Tarek Mekhail, et al.BMJ Open|August 4, 2023
CompreHensive geriAtRician-led MEdication Review (CHARMER): protocol for a feasibility study of a hospital deprescribing behaviour change interventionSion Scott, Bethany Atkins, Jacqueline M Martin-Kerry, et al.Journal of Neuroinflammation|March 1, 2014
Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomesPeter J Crack, Moses Zhang, Maria Cristina Morganti-Kossmann, et al.American Journal of Obstetrics and Gynecology|March 6, 2018
Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unitDavid Wright, Daniel L Rolnik, Argyro Syngelaki, et al.Pageof 48